Foxo1 was identified as a negative intrinsic regulator of NK cell homing, late-stage maturation, and effector functions, and it can directly target IFN-γ expression; moreover, Foxo1 deficiency increases the NK cell killing capacity of tumor cells ex vivo and the antimetastatic activity in vivo. The gene discussed is FOXO1; the disease is neoplasm.